Thermo Fisher Scientific (TMO) Q1 2026 Earnings
Thermo Fisher Scientific reported Q1 2026 revenue of $11.0B (+6.2% YoY), beat analyst consensus of $10.9B by $140.3M. Diluted EPS came in at $5.44 (+5.6% YoY), beat the $5.25 consensus by $0.19. Thermo Fisher Scientific reports across 4 business segments, led by Life Sciences Solutions, Laboratory Products and Biopharma Services, and Analytical Instruments.
Q1 2026 Earnings FAQ
Common questions about Thermo Fisher Scientific's Q1 2026 earnings report.
Thermo Fisher Scientific (TMO) reported Q1 2026 earnings on April 23, 2026 before market open.
Thermo Fisher Scientific reported revenue of $11.0B and diluted EPS of $5.44 for Q1 2026.
Revenue beat the consensus estimate of $10.9B by $140.3M. EPS beat the consensus estimate of $5.25 by $0.19.
Compared to the same quarter a year prior, revenue grew 6.2% from $10.4B a year earlier and diluted EPS grew 5.6% from $5.15.
Thermo Fisher Scientific reports across 4 business segments, led by Life Sciences Solutions, Laboratory Products and Biopharma Services, and Analytical Instruments. Segment-level financials are available on the company's metrics pages.
You can read the 8-K earnings release (0000097745-26-000086) directly on SEC EDGAR. The filing index links above go to sec.gov.